A case of high‐risk AML in a patient with advanced systemic mastocytosis
oleh: Manlio Fazio, Calogero Vetro, Uroš Markovic, Andrea Duminuco, Marina Parisi, Cinzia Maugeri, Elisa Mauro, Nunziatina Laura Parrinello, Fabio Stagno, Loredana Villari, Anna Maria Triolo, Stefania Stella, Giuseppe A. Palumbo, Francesco Di Raimondo, Alessandra Romano, Roberta Zanotti
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2023-07-01 |
Deskripsi
Abstract Aggressive SM + AML has limited therapeutic options. Even a strong combination of decitabine–venetoclax–midostaurin has a transient effect on AML and a mitigated effect on SM. Larger series are required to identify the best therapeutic strategy.